Shares of MetLife, Inc. (NYSE:MET – Get Free Report) have received a consensus recommendation of “Buy” from the twelve analysts that are covering the stock, MarketBeat Ratings reports. Twelve research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last year is $104.31.
Several analysts have recently weighed in on the stock. Wells Fargo & Company increased their price target on shares of MetLife from $101.00 to $109.00 and gave the company an “overweight” rating in a research note on Wednesday, August 19th. Piper Sandler upgraded MetLife from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $99.00 to $110.00 in a report on Tuesday. TD Cowen increased their price objective on MetLife from $87.00 to $105.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Barclays lifted their target price on MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Finally, UBS Group increased their price target on MetLife from $102.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th.
Read Our Latest Report on MetLife
Hedge Funds Weigh In On MetLife
MetLife Stock Down 0.0%
NYSE MET opened at $97.16 on Friday. The business’s fifty day simple moving average is $96.28 and its 200-day simple moving average is $85.69. The company has a quick ratio of 0.20, a current ratio of 0.20 and a debt-to-equity ratio of 0.52. The firm has a market cap of $62.52 billion, a PE ratio of 18.61, a P/E/G ratio of 0.92 and a beta of 0.77. MetLife has a 52 week low of $67.33 and a 52 week high of $100.93.
MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.13. MetLife had a net margin of 4.57% and a return on equity of 23.39%. The firm had revenue of $13.52 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period last year, the business earned $2.02 earnings per share. MetLife’s revenue was up 10.5% compared to the same quarter last year. As a group, equities analysts anticipate that MetLife will post 9.79 earnings per share for the current year.
MetLife declared that its Board of Directors has authorized a stock buyback program on Wednesday, August 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to reacquire up to 4.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.
MetLife Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th were given a $0.5925 dividend. The ex-dividend date of this dividend was Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. MetLife’s dividend payout ratio is presently 45.40%.
About MetLife
MetLife, Inc (NYSE: MET) is a global financial services company that provides insurance, employee benefits and retirement solutions to individuals, employers and institutions. Its offerings include life insurance, dental and vision insurance, disability coverage, accident and health insurance, annuities, and retirement products.
Through its employer-focused business, MetLife helps organizations provide benefits and financial protection to their employees. The company also offers group insurance, individual protection products and investment management services through MetLife Investment Management, which serves institutional investors and retirement plans.
Founded in 1868, MetLife serves customers in the United States and operates internationally across Latin America, Asia, Europe and the Middle East.
See Also
- Five stocks we like better than MetLife
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
